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The large subunit of ribonucleotide reductase from mouse has been overexpressed m Spodoptera fiugrperda cells infected with recombinant 
baculovirus. The expressed protein was purified by affinity chromatography to apparent homogeneity as determined by SDS-PAGE. The 
homogeneous protein IS recognized in Western blot analysis by a monoclonal antibody raised to the large subunit of ribonucleotide reductase from 
calf thymus. has the correct N-terminal sequence, and, in the presence of the small subunit of mouse ribonucleotide reductase and nucleoside 
triphosphate effecters, catalyzes the reduction of both purine and pyrtmidine nucleoside dtphosphates. 
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1. INTRODUCTION 
Ribonucleotide reductase (RR) catalyzes the reduc- 
tion of ribonucleoside diphosphate substrates to gener- 
ate the deoxyribonucleotide precursors necessary for 
DNA biosynthesis. Mammalian RR is an allosteric en- 
zyme comprised of two homodimeric subunits denoted 
Rl and R2, the expression of which are differentially 
regulated during the cell cycle [ 11. Mouse and human R2 
have been cloned [2.3] and an active form of recombi- 
nant R2 subunit has been purified from an E. coli ex- 
pression system [4]. The Rl subunit, which contains the 
binding sites for the allosteric effecters, has also been 
cloned [2,5]. Up to now, cloned Rl has not been ex- 
pressed in a soluble form capable of binding R2 and 
catalyzing the RR reaction. Furthermore, only limited 
amounts of Rl can be prepared conveniently from calf 
thymus. As a result, detailed mechanistic and structural 
studies of purified eukaryotic enzyme [6-lo] have been 
narrow in scope. Here we report the expression and 
purification of active mouse Rl in baculovirus infected 
Spodoptera frugiperda (Sf9) cells. Recombinant Rl was 
approximately 8% of the total soluble protein in in- 
fected Sf9 cells and was purified in one step using an 
FTLDADF-Sepharose affinity column [9]. 
using PCR primers (mR 1 -N ter S-GGGGGCTAGCATGCATGT- 
GATCAAG-3’ and mRl-Cter 5’-GGGGGCTAGCTCAGGATC- 
CACACATCAG-3’) that add NheI restriction sites (underlined) to the 
ends of the DNA fragment. The amplification product was digested 
with NhrI and inserted mto the NheI site of pBlueBac2 (InVitrogen). 
Sf9 cells were transformed with the recombinant plasmid using the 
cationic liposome method [ll]. Positive clones were selected by p- 
galactosidase blue/white screening and subsequently grown in 3 ml 
volumes in a 24-well dish. Plaques were subjected to PCR analysis with 
primers complementary to the polyhedron loci, BlueF 5’-TTTACTG 
TTTTCGTAACAGTTTTG-3’ and BlueR 5’-CAACAACGCACAG 
AATCTAG-3’ (InVitrogen), to select those free of non-recombinant 
baculovtrus. 
2.2 Grotvth and matntmunce of Sf9 cells 
Spodoptera frugiperda (Sf9) cells are cultured at 27°C in Excel1 400 
medium (JRH Scienttfic) supplemented with 10% heat inactivated 
FCS (BRL), 50 ,@ml gentamycm and 2.5 ,@ml Fungtzone that has 
been sterile filtered Cells grown in spinner flasks are also supple- 
mented with 0.1% Pluronic F-68 (JRH Scientific) to reduce shear 
damage. 
2.3. Exprewon of recombrnant RI 
2. MATERIALS AND METHODS 
2.1. Construcrlon of the wctor 
Original stocks of recombinant virus were used to infect virgin Sf9 
cells to screen for protein production and generate the second genera- 
tion of virus. Approximately 2 x lo6 cells were adhered to each well 
of a 24-well dish in a 3 ml volume and infected with 20, 100 and 500 
~1 of recombinant virus. Aliquots were removed and assayed for ex- 
pression of Rl every 24 h for 4 days. Plaque number C3 was selected 
for further study. For large scale expression of Rl protein. 50 ml of 
cells were grown to a density of 1.3 x lo6 cells/ml and infected with 10R 
virus particles, Cells were grown for 60-72 h then harvested by centrif- 
ugation at 1,000 x g for 10 min. 
The cDNA encoding the mouse ribonucleottde reductase (Rl) was 
a gift from Dr. Ingrid Caras (Genentech). The RI gene was amplified 
2.4. Purificatrorl of rrconlbmar~t RI 
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The cell pellet collected from a 50 ml culture was resuspended in 5 
ml of lysis buffer (50 mM Tris-Cl. pH 7.6.0.1 mM DTT, 2 mM PMSF) 
and subJected to two cycles of reeze-thaw. The lysate was centrifuged 
at 105.000 x g for 30 min. The resulting supernatant was loaded di- 
rectly onto an FTLDADF-Sepharose affinity column as previously 
described [9]. The column was washed with 50 mM Tris-Cl. 0.1 mM 
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DTT (buffer A) and then with buffer A + 100 mM KCl. Rl was eluted 
with 10 ml buffer A + 500 mM KCl. The column was regenerated by 
treatment with 6 M guamdme-HCl. Column fractions were monitored 
by the Bradford assay [13]. 
2.5. RR assays 
Ribonucleotide reductase activity was assayed at 37°C using the 
method of Moore and Peterson [13] with minor modificatrons. Briefly, 
assay mixtures contained 60 mM HEPES, pH 7.6.26 mM DTT, 7 mM 
NaF, 5 mM Mg(OAc),, 3 mM ATP. 0.05 mM FeCI,. and either lOpug 
of recombinant R2 prepared in our laboratories by the method of 
Mann et al. [4] or an equivalent volume of buffer A. For CDP reduc- 
tase assays, 0.05 mM [5-‘H]CDP (20 Ct/mol) was added to assay mix, 
while for GDP reductase assays 1.5 mM dTTP and 0.02 mM 
[7,8-‘H]GDP (45 Ci/mol) were added to a final volume of 100 ~1. 
Reactions were imtiated by the addition of protein and incubated at 
37°C for 5-15 min for initial rate determmattons. Reactions were 
quenched by immersion m a bothng water bath for 4 min. Samples 
were frozen and lyophihzed to dryness. Lyophthzed samples were 
reconstituted in I ml of 50 mM Tris, pH 8.45 containing 100 mM 
Mg(OAc), (buffer B). Samples were centrifuged at 10,000 x g for 10 
mm to prectpitate denatured protein. The supernatant was then loaded 
onto 0.5 x 5 cm columns of aminophenylboronate (Amtcon) which 
had been pre-equilibrated with 5 ml of buffer B. Deoxynucleoside 
dtphosphates elute in 5 ml (for dCDP) to I2 ml (for dGDP) of buffer 
B. Unreacted ribonucleoside diphosphate substrates can be quanttta- 
ttvely recovered and columns can be regenerated by treatment with 10 
ml of 50 mM sodium citrate. pH 5.9. Radioacttvity in ahquots of both 
buffer B and citrate fractions were determined by liquid scmtillation 
counting. 
2.6. Ot/~er methods 
A partial N-terminal sequence of the purified protein was deter- 
mined by the Edman method [I41 using an Applied Biosystems model 
473A sequencer. SDS polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed using 7.5% acrylamide as described by 
Laemmh [15] Western blots were performed as described [16] usmg 
monoclonal antibody AC1 (In Ro BroMedTek. Umeb, Sweden) raised 
agamst Rl from calf thymus. Protein concentratton was determined 
according to Bradford [12]. 
3. RESULTS AND DISCUSSION 
Initial attempts to produce active recombinant Rl in 
two E. coli expression systems, pZM [ 161 and PET [17], 
resulted in large quantities of insoluble protein in cyto- 
plasmic inclusion bodies. The gene was subsequently 
inserted into the NheI site of pBlueBac2 for expression 
in St9 cells. After transfection, nine recombinant 
plaques were selected for further analysis. Putative pos- 
itive clones were subjected to PCR analysis using prim- 
ers that anneal to the polyhedron region and span the 
recombinant R 1 gene. Of the selected plaques, only one 
contained an insert which was free of non-recombinant 
viral contamination. This sample, designated C3, was 
isolated for further study. 
Sf9 cells were infected with recombinant virus stock, 
C3, at a multiplicity of infection of 1. Crude extracts, 
prepared by two cycles of freezing and thawing, were 
screened for RI production by SDS-PAGE, Western 
blot and CDP reductase activity assays. Sf9 cells in- 
fected with ap-galactosidase producing baculovirus (In- 
Vitrogen) as well as uninfected Sf9 cells served as con- 
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Fig. 1. SDS-PAGE (top) and Western blot (bottom) analysis of recom- 
binant Rl. Low m.wt. markers/prestamed low m.wt. markers, 
phosphorylase h 97.4/106 kDa. BSA 66.X30 kDa, ovalbumin 45/49.5 
kDa, carbonic anhydrase 31/32.5 kDa. trypsm inhibitor 21.5/27.5, 
lysozyme 14.4/18.5 (lane 1 top/lane 1 bottom). authentic calf thymus 
RI (lane 2) soluble cell lysate from unmfected Sf9 cells (lane 3). 
soluble cell lysate from Sf9 cells infected with baculovirus expressing 
/I-galactosidase (lane 4). soluble cell lysate from Sf9 cells Infected with 
recombinant vnus stock C3 (lane 5). buffer A wash of C3-infected Sf9 
cell lysate loaded FTLDADF-Sepharose column (lane 6). buffer 
A + 500 mM KC1 wash of C3-infected Sf9 cell lysate loaded 
FTLDADF-Sepharose column (lane 7) 
trols. No endogenous RR activity was detected in any 
soluble Sf9 cell lysate in the absence of recombinant R2 
and no RR activity was detected in the crude lysates of 
either of the control cells in the presence of added re- 
combinant R2. The level of Rl production in cells in- 
fected with recombinant virus was determined by assay- 
ing the crude lysate in the presence of recombinant R2. 
In 50 ml spinner flasks, Rl production was found to be 
independent of multiplicity of infection ranging from 1 
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Table I 
Purification of Rl on FTLDADF-Sepharose 
Fraction 
Crude lysate 
[KCI] = 0 
[KCI] = 100 mM 
[KCI] = 500 mM 
6 M guanidme-HC1 
Protein (mg) Activity (units) 
18 145 
14.4 20 
0.1 <4 
0.9 90 
0.4 ND 
Specific activtty 
8 
1.4 
_ 
100 
ND 
% Crude activity 
100 
13 
<3 
62 
ND 
One unit of activity is defined as the amount of protein required to produce 1 nmol of dCDP from CDP in 1 min. Specific activity is defined as 
nmol dCDP/min/mg protem. Protein concentrations are by Bradford and represent the average of three measurements. All protein activities were 
determined in duplicate with a variance of < 10%. 
to 100. An incubation of 2-3 days was found to be 
optimal for the expression of this protein. 
Western blot analysis shows the presence of a high 
molecular weight cross-reacting protein in the crude 
lysates of both C3-infected and control cells (Fig. 1, 
bottom). This protein may correspond to Spodoptera 
Rl. If it does, then the lack of reductase activity upon 
addition of recombinant mouse R2 to control cell ex- 
tracts would imply that mouse R2 is not able to form 
a productive complex with insect R 1. The C-terminus 
of insect R2 may thus differ significantly from that of 
mouse R2 [9,18]. 
The purification of Rl on FTLDADF-Sepharose is 
described in Table I. The Rl protein was produced as 
8% of the soluble protein in C3-infected St9 cells. 62% 
of Rl activity was collected as a homogeneous protein 
of molecular weight 85 kDa in the 500 mM KC1 fraction 
(Fig. 1, column 7). More than 85% of the total protein 
loaded onto the column was recovered, and 75% of the 
reductase activity was accounted for. One preparation 
of purified Rl had a specific activity of 201 + 11 U/mg 
for CDP reductase and 142 & 13 U/mg for GDP reduc- 
tase. Under the same conditions, Rl purified from calf 
thymus [9] gave specific activities for CDP and GDP 
reductase of 46 ? 5 U/mg and 32 & 3 U/mg, respec- 
tively. Purification of a second lot of recombinant Rl 
which was contaminated with a lower molecular weight 
species, which appears to be a cleavage product, gave 
a specific activity of 100 f 7 for CDP reductase. N- 
terminal analysis of the protein in the 500 mM KC1 
fraction gave a result that is consistent with that derived 
from the Rl gene sequence ~ MHVIKRDGR. 
SDS-PAGE and Western blot analysis of the protein 
eluted by guanidine-HCl showed it to be predominantly 
Rl. This indicates that future enhancements to this 
preparation may afford an even greater yield. Presently, 
purification of recombinant Rl from these cells takes 
less than a day, which compares favorably with the four 
to five days required for preparation of Rl from calf 
thymus. 
In conclusion, we have succeeded in expressing R 1 in 
baculovirus-infected St9 cells and purifying large quan- 
tities in good yield by a rapid one step procedure. This 
represents the first published expression of an active 
eukaryotic recombinant Rl. It will now be possible to 
carry out detailed biochemical and structural experi- 
ments on the fully reconstituted mouse RR enzyme 
using recombinant Rl and recombinant R2. In addi- 
tion, the baculovirus expression system is convenient 
for screening and production of mutant Rl proteins 
without an interfering background of Sf9 Rl. 
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